| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression | 12 | 2024 | 506 | 2.190 |
Why?
|
| Suicide | 10 | 2024 | 124 | 2.100 |
Why?
|
| Autism Spectrum Disorder | 8 | 2024 | 164 | 1.570 |
Why?
|
| Health Care Costs | 9 | 2022 | 229 | 1.570 |
Why?
|
| Adolescent | 50 | 2025 | 3690 | 1.480 |
Why?
|
| Depressive Disorder | 14 | 2019 | 222 | 1.450 |
Why?
|
| Depressive Disorder, Major | 7 | 2022 | 124 | 1.440 |
Why?
|
| Humans | 96 | 2025 | 17822 | 1.360 |
Why?
|
| Female | 75 | 2025 | 12780 | 1.270 |
Why?
|
| Behavior Therapy | 6 | 2023 | 146 | 1.240 |
Why?
|
| Male | 66 | 2025 | 10145 | 1.230 |
Why?
|
| Mental Health Services | 12 | 2019 | 159 | 1.200 |
Why?
|
| Cost-Benefit Analysis | 8 | 2021 | 250 | 1.140 |
Why?
|
| Quality of Life | 5 | 2023 | 511 | 1.110 |
Why?
|
| Primary Health Care | 9 | 2022 | 770 | 1.110 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 3 | 2022 | 14 | 1.090 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2022 | 391 | 1.070 |
Why?
|
| Suicidal Ideation | 5 | 2025 | 101 | 1.030 |
Why?
|
| Anxiety | 5 | 2023 | 151 | 1.000 |
Why?
|
| Mental Disorders | 10 | 2022 | 280 | 0.990 |
Why?
|
| Health Maintenance Organizations | 17 | 2012 | 417 | 0.980 |
Why?
|
| Mobile Applications | 1 | 2025 | 19 | 0.940 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 214 | 0.900 |
Why?
|
| Health Personnel | 1 | 2025 | 126 | 0.880 |
Why?
|
| Anxiety Disorders | 8 | 2023 | 91 | 0.870 |
Why?
|
| Serotonin Uptake Inhibitors | 5 | 2013 | 71 | 0.810 |
Why?
|
| Child | 25 | 2024 | 2497 | 0.800 |
Why?
|
| Suicide, Attempted | 4 | 2022 | 102 | 0.790 |
Why?
|
| Patient Acuity | 1 | 2022 | 7 | 0.780 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2023 | 537 | 0.780 |
Why?
|
| Cost of Illness | 3 | 2014 | 93 | 0.760 |
Why?
|
| United States | 31 | 2024 | 4007 | 0.760 |
Why?
|
| Opioid-Related Disorders | 3 | 2014 | 172 | 0.750 |
Why?
|
| Adult | 40 | 2025 | 7708 | 0.750 |
Why?
|
| Combined Modality Therapy | 6 | 2014 | 147 | 0.740 |
Why?
|
| Substance-Related Disorders | 7 | 2020 | 434 | 0.720 |
Why?
|
| Psychotic Disorders | 4 | 2024 | 44 | 0.650 |
Why?
|
| Patient Health Questionnaire | 3 | 2024 | 18 | 0.640 |
Why?
|
| Genetic Carrier Screening | 5 | 2018 | 16 | 0.600 |
Why?
|
| Psychotropic Drugs | 8 | 2017 | 36 | 0.570 |
Why?
|
| Delivery of Health Care | 5 | 2018 | 417 | 0.570 |
Why?
|
| Middle Aged | 28 | 2024 | 8020 | 0.550 |
Why?
|
| Buprenorphine | 2 | 2014 | 48 | 0.550 |
Why?
|
| Patient Selection | 4 | 2020 | 190 | 0.550 |
Why?
|
| Psychology, Adolescent | 1 | 2016 | 14 | 0.550 |
Why?
|
| Self Care | 5 | 2011 | 163 | 0.550 |
Why?
|
| Binge-Eating Disorder | 3 | 2010 | 13 | 0.520 |
Why?
|
| Medicaid | 7 | 2013 | 190 | 0.490 |
Why?
|
| Health Policy | 2 | 2014 | 123 | 0.460 |
Why?
|
| Child, Preschool | 14 | 2024 | 1424 | 0.460 |
Why?
|
| Genetic Testing | 7 | 2023 | 72 | 0.460 |
Why?
|
| Antidepressive Agents | 6 | 2018 | 156 | 0.460 |
Why?
|
| Motivation | 3 | 2023 | 131 | 0.460 |
Why?
|
| Adolescent Behavior | 2 | 2013 | 127 | 0.450 |
Why?
|
| Commerce | 1 | 2014 | 48 | 0.450 |
Why?
|
| Child of Impaired Parents | 6 | 2016 | 33 | 0.440 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2014 | 228 | 0.440 |
Why?
|
| Treatment Outcome | 14 | 2022 | 1265 | 0.440 |
Why?
|
| Surveys and Questionnaires | 9 | 2022 | 1323 | 0.430 |
Why?
|
| Bulimia Nervosa | 3 | 2010 | 10 | 0.430 |
Why?
|
| Cyclohexanols | 4 | 2013 | 36 | 0.420 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2018 | 8 | 0.410 |
Why?
|
| Retrospective Studies | 11 | 2024 | 2467 | 0.410 |
Why?
|
| Parents | 6 | 2017 | 297 | 0.410 |
Why?
|
| Case-Control Studies | 9 | 2022 | 1120 | 0.400 |
Why?
|
| Bipolar Disorder | 3 | 2020 | 59 | 0.380 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 1219 | 0.380 |
Why?
|
| Manuals as Topic | 2 | 2010 | 7 | 0.370 |
Why?
|
| Antipsychotic Agents | 3 | 2024 | 49 | 0.360 |
Why?
|
| Methadone | 1 | 2010 | 10 | 0.360 |
Why?
|
| Prepaid Health Plans | 1 | 2010 | 20 | 0.360 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 329 | 0.350 |
Why?
|
| Opiate Substitution Treatment | 1 | 2010 | 46 | 0.350 |
Why?
|
| Schizophrenia | 3 | 2024 | 77 | 0.340 |
Why?
|
| Child Health | 2 | 2023 | 35 | 0.340 |
Why?
|
| Health Care Surveys | 2 | 2017 | 230 | 0.340 |
Why?
|
| Life Style | 1 | 2012 | 334 | 0.340 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2019 | 64 | 0.340 |
Why?
|
| State Health Plans | 2 | 2000 | 35 | 0.340 |
Why?
|
| Overweight | 1 | 2012 | 270 | 0.330 |
Why?
|
| Weight Loss | 1 | 2012 | 305 | 0.320 |
Why?
|
| Preconception Care | 4 | 2018 | 44 | 0.320 |
Why?
|
| Preventive Health Services | 3 | 2016 | 160 | 0.300 |
Why?
|
| Psychiatric Status Rating Scales | 9 | 2017 | 125 | 0.290 |
Why?
|
| Risk Factors | 9 | 2022 | 3362 | 0.290 |
Why?
|
| Qualitative Research | 3 | 2025 | 256 | 0.280 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 45 | 0.270 |
Why?
|
| Electronic Health Records | 7 | 2023 | 698 | 0.270 |
Why?
|
| Age Factors | 4 | 2020 | 923 | 0.260 |
Why?
|
| Family Planning Services | 2 | 2016 | 20 | 0.260 |
Why?
|
| Genome, Human | 2 | 2016 | 32 | 0.260 |
Why?
|
| Young Adult | 10 | 2024 | 2464 | 0.260 |
Why?
|
| Mammography | 2 | 2023 | 169 | 0.250 |
Why?
|
| Health Status | 3 | 2020 | 299 | 0.250 |
Why?
|
| Patient Compliance | 4 | 2019 | 301 | 0.250 |
Why?
|
| Ethnic Groups | 4 | 2019 | 485 | 0.250 |
Why?
|
| Mental Health | 3 | 2023 | 166 | 0.250 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 957 | 0.240 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2013 | 332 | 0.240 |
Why?
|
| Health Expenditures | 3 | 2018 | 76 | 0.240 |
Why?
|
| Rural Population | 1 | 2024 | 52 | 0.230 |
Why?
|
| Clozapine | 1 | 2024 | 5 | 0.230 |
Why?
|
| Vaginal Smears | 1 | 2004 | 48 | 0.220 |
Why?
|
| Community-Institutional Relations | 1 | 2004 | 43 | 0.220 |
Why?
|
| Genetic Counseling | 4 | 2016 | 26 | 0.220 |
Why?
|
| Aged | 9 | 2022 | 6173 | 0.220 |
Why?
|
| Patient Care | 1 | 2023 | 35 | 0.220 |
Why?
|
| Health Services | 3 | 2015 | 113 | 0.220 |
Why?
|
| Chronic Pain | 1 | 2024 | 127 | 0.210 |
Why?
|
| Drug Utilization | 5 | 2003 | 128 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 30 | 0.200 |
Why?
|
| Utilization Review | 3 | 2018 | 53 | 0.200 |
Why?
|
| Minority Groups | 1 | 2023 | 101 | 0.200 |
Why?
|
| Child Abuse | 1 | 2023 | 44 | 0.200 |
Why?
|
| Cohort Studies | 2 | 2022 | 2590 | 0.200 |
Why?
|
| Natural Language Processing | 1 | 2023 | 58 | 0.200 |
Why?
|
| Alcohol Drinking | 2 | 2004 | 373 | 0.200 |
Why?
|
| Venlafaxine Hydrochloride | 4 | 2013 | 37 | 0.190 |
Why?
|
| Longitudinal Studies | 4 | 2017 | 720 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2024 | 1103 | 0.190 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2012 | 28 | 0.190 |
Why?
|
| Infant | 7 | 2024 | 1198 | 0.190 |
Why?
|
| Community Mental Health Services | 2 | 2002 | 33 | 0.190 |
Why?
|
| Telemedicine | 1 | 2024 | 187 | 0.180 |
Why?
|
| Prevalence | 5 | 2024 | 888 | 0.180 |
Why?
|
| Oregon | 7 | 2006 | 181 | 0.180 |
Why?
|
| Sex Factors | 4 | 2020 | 644 | 0.180 |
Why?
|
| Genomics | 2 | 2018 | 55 | 0.180 |
Why?
|
| Genetic Research | 1 | 2020 | 8 | 0.180 |
Why?
|
| Prospective Studies | 2 | 2023 | 1286 | 0.170 |
Why?
|
| Social Change | 1 | 2000 | 1 | 0.170 |
Why?
|
| Behavior Control | 1 | 2000 | 4 | 0.170 |
Why?
|
| Child Behavior Disorders | 1 | 2000 | 17 | 0.170 |
Why?
|
| Managed Care Programs | 4 | 2010 | 325 | 0.170 |
Why?
|
| Models, Psychological | 1 | 2019 | 23 | 0.170 |
Why?
|
| Health Plan Implementation | 1 | 2000 | 36 | 0.170 |
Why?
|
| Benzodiazepines | 1 | 2019 | 29 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 37 | 0.160 |
Why?
|
| Machine Learning | 1 | 2019 | 46 | 0.160 |
Why?
|
| Patient Participation | 1 | 2020 | 134 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 630 | 0.160 |
Why?
|
| Psychotherapy, Brief | 2 | 2017 | 20 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2019 | 158 | 0.150 |
Why?
|
| Neonatal Screening | 1 | 2018 | 11 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2004 | 326 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 34 | 0.150 |
Why?
|
| Psychotherapy | 2 | 2016 | 59 | 0.150 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2018 | 38 | 0.150 |
Why?
|
| Patient Care Planning | 1 | 2018 | 53 | 0.140 |
Why?
|
| Skin Diseases | 1 | 2017 | 10 | 0.140 |
Why?
|
| Decision Making | 5 | 2016 | 184 | 0.140 |
Why?
|
| Neoplasms | 1 | 2022 | 445 | 0.140 |
Why?
|
| Public Health Administration | 1 | 1997 | 6 | 0.140 |
Why?
|
| State Government | 1 | 1997 | 14 | 0.140 |
Why?
|
| Health Care Rationing | 1 | 1997 | 12 | 0.140 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 115 | 0.140 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2017 | 9 | 0.140 |
Why?
|
| Interview, Psychological | 1 | 2016 | 19 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 52 | 0.140 |
Why?
|
| Truth Disclosure | 1 | 2016 | 15 | 0.130 |
Why?
|
| Counseling | 2 | 2015 | 189 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2012 | 967 | 0.130 |
Why?
|
| Preimplantation Diagnosis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Incidence | 3 | 2017 | 1269 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2017 | 183 | 0.120 |
Why?
|
| Psychotherapy, Group | 3 | 2013 | 26 | 0.120 |
Why?
|
| Comorbidity | 6 | 2014 | 597 | 0.120 |
Why?
|
| Washington | 4 | 2023 | 383 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 1335 | 0.120 |
Why?
|
| Drug Resistance | 2 | 2012 | 32 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2014 | 70 | 0.110 |
Why?
|
| Pneumonia | 1 | 2014 | 51 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 28 | 0.110 |
Why?
|
| Off-Label Use | 1 | 2013 | 14 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 88 | 0.110 |
Why?
|
| Anorexia Nervosa | 2 | 2010 | 5 | 0.110 |
Why?
|
| Secondary Prevention | 2 | 2010 | 48 | 0.110 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 10 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2015 | 302 | 0.110 |
Why?
|
| Drug Prescriptions | 1 | 2014 | 151 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 186 | 0.110 |
Why?
|
| Research Design | 1 | 2015 | 376 | 0.100 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2004 | 75 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2014 | 264 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2014 | 164 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 238 | 0.100 |
Why?
|
| Program Development | 2 | 2011 | 69 | 0.100 |
Why?
|
| Anhedonia | 1 | 2012 | 5 | 0.100 |
Why?
|
| Internet | 2 | 2005 | 231 | 0.100 |
Why?
|
| Risk | 3 | 2019 | 518 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2013 | 455 | 0.100 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 55 | 0.090 |
Why?
|
| Bulimia | 1 | 2011 | 8 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2017 | 169 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 376 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 246 | 0.090 |
Why?
|
| Cost Savings | 1 | 2010 | 24 | 0.090 |
Why?
|
| Diet | 1 | 2012 | 366 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 305 | 0.080 |
Why?
|
| Health Behavior | 1 | 2012 | 360 | 0.080 |
Why?
|
| Heart Failure | 1 | 2014 | 396 | 0.080 |
Why?
|
| Self-Help Groups | 1 | 2009 | 30 | 0.080 |
Why?
|
| Psychometrics | 3 | 2017 | 121 | 0.080 |
Why?
|
| Time Factors | 4 | 2014 | 1097 | 0.080 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 27 | 0.080 |
Why?
|
| Focus Groups | 3 | 2016 | 147 | 0.070 |
Why?
|
| Health Services Research | 3 | 2018 | 232 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2023 | 858 | 0.070 |
Why?
|
| Feeding and Eating Disorders | 1 | 2007 | 17 | 0.070 |
Why?
|
| Exercise | 1 | 2012 | 495 | 0.070 |
Why?
|
| Northwestern United States | 3 | 2017 | 53 | 0.070 |
Why?
|
| Terminology as Topic | 2 | 2016 | 17 | 0.070 |
Why?
|
| Exome | 2 | 2016 | 21 | 0.060 |
Why?
|
| Heterozygote | 2 | 2016 | 26 | 0.060 |
Why?
|
| Incidental Findings | 2 | 2016 | 26 | 0.060 |
Why?
|
| Interviews as Topic | 3 | 2018 | 305 | 0.060 |
Why?
|
| Logistic Models | 3 | 2019 | 928 | 0.060 |
Why?
|
| Pain Management | 1 | 2024 | 58 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2004 | 73 | 0.060 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2024 | 61 | 0.060 |
Why?
|
| Ambulatory Care | 2 | 2018 | 247 | 0.060 |
Why?
|
| Time and Motion Studies | 1 | 2023 | 3 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 4 | 0.050 |
Why?
|
| Citalopram | 1 | 2013 | 14 | 0.050 |
Why?
|
| Remission Induction | 1 | 2013 | 26 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2013 | 26 | 0.050 |
Why?
|
| Paroxetine | 1 | 2013 | 23 | 0.050 |
Why?
|
| Veterans | 1 | 2024 | 143 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 25 | 0.050 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2003 | 33 | 0.050 |
Why?
|
| Gender Identity | 1 | 2002 | 36 | 0.050 |
Why?
|
| Women's Health | 1 | 2004 | 202 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 18 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2023 | 85 | 0.050 |
Why?
|
| Adjustment Disorders | 1 | 2002 | 2 | 0.050 |
Why?
|
| Mastectomy | 1 | 2022 | 36 | 0.050 |
Why?
|
| Pregnancy | 2 | 2018 | 1529 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 12 | 0.040 |
Why?
|
| California | 2 | 2017 | 2328 | 0.040 |
Why?
|
| Methylphenidate | 1 | 2000 | 4 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 381 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2000 | 55 | 0.040 |
Why?
|
| Oceanic Ancestry Group | 1 | 2019 | 33 | 0.040 |
Why?
|
| Indians, North American | 1 | 2019 | 49 | 0.040 |
Why?
|
| Mentoring | 1 | 2019 | 26 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2018 | 2 | 0.040 |
Why?
|
| Asian Americans | 1 | 2019 | 176 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 810 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2018 | 10 | 0.040 |
Why?
|
| Income | 1 | 2018 | 90 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 20 | 0.040 |
Why?
|
| Personality Assessment | 2 | 2012 | 15 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 513 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 253 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 72 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 321 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2019 | 404 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 1997 | 15 | 0.040 |
Why?
|
| Ohio | 1 | 1997 | 23 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2000 | 292 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 529 | 0.030 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2017 | 4 | 0.030 |
Why?
|
| Financing, Government | 1 | 1997 | 28 | 0.030 |
Why?
|
| Taxes | 1 | 1997 | 24 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 48 | 0.030 |
Why?
|
| African Americans | 1 | 2019 | 472 | 0.030 |
Why?
|
| Colorado | 1 | 2017 | 164 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2016 | 33 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 48 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 40 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 212 | 0.030 |
Why?
|
| Family | 1 | 2016 | 112 | 0.030 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2014 | 3 | 0.030 |
Why?
|
| Insurance Claim Reporting | 1 | 2014 | 7 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2015 | 165 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2013 | 33 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 45 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2014 | 69 | 0.030 |
Why?
|
| Drug Substitution | 1 | 2012 | 10 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 25 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 160 | 0.020 |
Why?
|
| Adolescent Health Services | 1 | 2001 | 43 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 85 | 0.020 |
Why?
|
| Psychopathology | 1 | 2010 | 4 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2010 | 14 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2010 | 15 | 0.020 |
Why?
|
| Body Image | 1 | 2010 | 21 | 0.020 |
Why?
|
| Child Health Services | 1 | 2001 | 113 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 166 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 58 | 0.020 |
Why?
|
| Office Visits | 1 | 2007 | 80 | 0.020 |
Why?
|
| Cost Control | 1 | 2006 | 21 | 0.020 |
Why?
|
| Observer Variation | 1 | 2005 | 37 | 0.020 |
Why?
|
| Cues | 1 | 2005 | 10 | 0.020 |
Why?
|
| Recurrence | 1 | 2005 | 189 | 0.010 |
Why?
|
| Telephone | 1 | 2005 | 161 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 239 | 0.010 |
Why?
|
| Case Management | 1 | 2004 | 33 | 0.010 |
Why?
|
| Weight Gain | 1 | 2005 | 173 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 159 | 0.010 |
Why?
|
| Retention (Psychology) | 1 | 2002 | 7 | 0.010 |
Why?
|
| Family Relations | 1 | 2003 | 16 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2002 | 22 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 190 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 85 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 246 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 315 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 213 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 1931 | 0.010 |
Why?
|